Los Angeles Capital Management’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.19M | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $1.22M | Sell |
|
|||||
|
2024
Q1 | $491K | Buy |
|
|||||
|
2023
Q4 | $388K | Sell |
|
|||||
|
2023
Q3 | $587K | Buy |
|
|||||
|
2023
Q2 | $659K | Buy |
|
|||||
|
2023
Q1 | $461K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $380K | Sell |
|
|||||
|
2021
Q3 | $882K | Buy |
|
|||||
|
2021
Q2 | $577K | Buy |
|
|||||
|
2021
Q1 | $828K | Sell |
|
|||||
|
2020
Q4 | $1.31M | Sell |
|
|||||
|
2020
Q3 | $1.53M | Buy |
|
|||||
|
2020
Q2 | $1.14M | Sell |
|
|||||
|
2020
Q1 | $936K | Hold |
|
|||||
|
2019
Q4 | $873K | Sell |
|
|||||
|
2019
Q3 | $1.2M | Sell |
|
|||||
|
2019
Q2 | $1.12M | Hold |
|
|||||
|
2019
Q1 | $1.17M | Sell |
|
|||||
|
2018
Q4 | $1.39M | Sell |
|
|||||
|
2018
Q3 | $1.82M | Sell |
|
|||||
|
2018
Q2 | $1.49M | Sell |
|
|||||
|
2018
Q1 | $1.77M | Sell |
|
|||||
|
2017
Q4 | $2.97M | Buy |
|
|||||
|
2017
Q3 | $1.05M | Buy |
|
|||||
|
2017
Q2 | $261K | Sell |
|
|||||
|
2017
Q1 | $305K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $207K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $722K | Sell |
|
|||||
|
2015
Q4 | $1.68M | Sell |
|
|||||
|
2015
Q3 | $1.23M | Buy |
|
|||||
|
2015
Q2 | $694K | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $354K | Buy |
|
|||||
|
2013
Q2 | $262K | Buy |
|